WARRINGTON, Pa., Feb. 1, 2021 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointment of Joseph Soffer, M.D., F.A.C.C., as Executive Director of Clinical Development, effective immediately. “We are thrilled to welcome Joe […]
Financial
JanOne Announces Closing of $6.0 Million Common Stock Offering
Net proceeds will help support planning of clinical trials for JAN101, the company’s lead drug candidate LAS VEGAS, Feb. 2, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the closing of previously announced its securities […]
Cytokinetics Announces Recipients of Third Annual Communications Fellowship Grants
Total of $100,000 Awarded to Five Organizations to Support Communications and Community Outreach SOUTH SAN FRANCISCO, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its third annual Communications Fellowship Grant program, intended to support increased capacity in communications, awareness building and community engagement […]
PhysIQ Expands Clinical Leadership Team, Dr. Steve Steinhubl Joins as Chief Medical Officer
CHICAGO–(BUSINESS WIRE)–Dr. Steve Steinhubl, a leader in reinventing medicine through the convergence of healthcare and technology and an expert in physiology, has joined physIQ as Chief Medical Officer. Dr. Steinhubl will help advance the adoption of physIQ’s artificial intelligence (AI)-based analytics for improved clinical outcomes and lower costs. “Over the […]
AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its fourth quarter and full year 2020 financial results on Tuesday, February 23, 2021. AtriCure will host a conference call at 4:30 p.m. Eastern […]
AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Richard C. Rosenzweig as Senior Vice President, General Counsel, effective January 31, 2021. Mr. Rosenzweig will also serve as Corporate Secretary […]
Hillrom Comments On Novitas Reimbursement Decision
CHICAGO, Jan. 31, 2021 /PRNewswire/ — Hillrom (NYSE: HRC) previously announced its intention to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ambulatory cardiac monitoring. On January 29, 2021, a Medicare Administrative Contractor (MAC), Novitas Solutions, published newly established, Category 1 reimbursement rates applicable to the Current Procedural […]
Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems
Company Focuses on Commercial Development, Revenue Generation and Operating Excellence JUPITER, Fla., Feb. 1, 2021 /PRNewswire/ — Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has added two life science industry […]
CARMAT Appoints Prof. Christian Latrémouille as Director of Surgical Affairs
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces the appointment of Professor Christian Latrémouille as Director of […]
NTT Research Names Jon Peterson MEI Lab Senior Scientist
Biomedical engineer specialized in cardiovascular systems to support bio digital twin initiative SUNNYVALE, Calif.–(BUSINESS WIRE)–NTT Research, Inc., a division of NTT (TYO:9432), today announced that it has named Dr. Jon Nels Peterson a Senior Scientist in its Medical & Health Informatics (MEI) Lab. Dr. Peterson, a biomedical engineer with both academic and medical […]
Recent
New HFSA Scientific Statement Provides Practical Guidance for Managing Heart Failure with Mildly Reduced Ejection Fraction
Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH™ Neurovascular Catheter
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Popular
- No commented posts yet